|
|
 |
|
Viewing report
|
|
|
|
The Future of Clinical Monitoring
Industry Standard Research (ISR), Dec 2010, Pages: 83
It turns out that clinical monitoring is in no immediate danger of going the way of the dinosaurs. In fact, two-thirds of the respondents indicated they would recommend their son or daughter become a CRA. Status quo then, right? Not so fast, the times are changing. Now what?
This report details the overall awareness, interest, and potential adoption of alternative models for clinical monitoring; it uncovers the barriers to adopting these models; it gets at what phases of development are appropriate for the various mix of monitoring models; analyzes what pricing models are best for this highly outsourced activity; and broadens the industry's understanding of how the clinical monitoring landscape will likely change over the next few years.
The 'now what' is a call to action. Biopharmaceutical sponsor companies are interested in alternative models for clinical monitoring and they portend some striking increases in their use. It is now up to the regulators, sponsors, technology providers, and clinical service providers to develop solutions that meet the industry's needs.
Product samples
A sample for this product is available. Please Login/Register to download this sample.
|
|
|
|
